ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 72 filers reported holding ALIGOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,949,425 | -23.1% | 3,948,360 | 0.0% | 0.10% | +5.3% |
| Q2 2023 | $3,833,858 | +11.1% | 3,948,360 | 0.0% | 0.09% | -15.3% |
| Q1 2023 | $3,450,867 | -8.3% | 3,948,360 | 0.0% | 0.11% | -3.5% |
| Q4 2022 | $3,762,392 | -13.4% | 3,948,360 | 0.0% | 0.12% | -10.2% |
| Q3 2022 | $4,343,000 | -9.1% | 3,948,360 | 0.0% | 0.13% | -22.4% |
| Q2 2022 | $4,778,000 | -43.7% | 3,948,360 | 0.0% | 0.16% | -38.0% |
| Q1 2022 | $8,489,000 | +685.3% | 3,948,360 | +4236.8% | 0.27% | +682.4% |
| Q4 2021 | $1,081,000 | – | 91,044 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |